Marathon Petroleum heads into its Q1 2026 earnings call with a broad wave of analyst upgrades behind it — and the stock trading just below the newly revised consensus.
The analyst backdrop is the standout setup here. In the six weeks before the print, every major firm that moved on MPC raised its price target. Morgan Stanley lifted its target to $233 on April 24 — just days before the release — while keeping an Overweight. Barclays moved to $230. UBS went to $280 and Wells Fargo to $331, both with positive ratings. The mean target across the Street now sits at $247, roughly 6% above the last close of $232.59. That is a narrow gap. With the stock up 5.6% on the week and 39.7% year-to-date, the market has already priced in much of the thesis the bulls have been rebuilding since March.
Options tell a calmer story than the price action might suggest. The put/call ratio is running at 0.65, almost exactly in line with its 20-day average of 0.64 — a z-score of just 0.70. There is no unusual scramble for downside protection. The PCR sat well above 0.80 as recently as mid-March, so the pullback in hedging demand reflects a genuine shift in mood rather than complacency. That said, the 52-week high on the PCR was 1.18, a reminder of how quickly the tone can change in a commodity-exposed name.
Short interest is not a story here. At 2% of free float — down more than 30% over the past month and off sharply from a mid-March peak near 3% — bears have largely stood aside ahead of the print. Borrow is effectively free at 0.36%, and availability remains generous, meaning there is no structural constraint on new short positions if sentiment sours. The ORTEX short score of 31 ranks in the 34th percentile relative to the market, confirming this is not a heavily contested stock. Peers PSX, VLO, and DINO all rallied 5-7% on the week, broadly in line with MPC's move, so the refiner group as a whole has recovered rather than diverged.
What the print will test is whether MPC's earnings-per-share trajectory justifies the multiple expansion already underway — the P/E has compressed 3.2 points over the past month even as the stock climbed, a sign that the earnings revision cycle is doing real work. EPS momentum ranks in the 87th percentile on a 90-day basis and in the 88th on surprise history, so the bar is high. The Q1 report will reveal whether crack spreads and throughput volumes held up well enough to sustain that momentum as the year progresses.
See the live data behind this article on ORTEX.
Open MPC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
